Yestar Healthcare Holdings Company Limited (HKG:2393)
Hong Kong · Delayed Price · Currency is HKD 0.0590
+0.0030 (5.36%)
Sep 9, 2026, 6:10 PM HKT
HKG:2393 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,349 | 1,490 | 2,410 | 2,913 | 2,805 | 4,931 | |
Revenue Growth | -30.42% | -38.17% | -17.26% | 3.86% | -43.12% | 20.06% |
Cost of Revenue | 1,071 | 1,223 | 2,011 | 2,400 | 2,407 | 4,082 |
Gross Profit | 277.93 | 266.86 | 399.2 | 512.78 | 397.55 | 848.7 |
Selling, General & Admin | 234.47 | 238.26 | 362.41 | 380.58 | 364.9 | 657.01 |
Operating Expenses | 262.24 | 254.65 | 338.57 | 341.74 | 504.38 | 664.33 |
Operating Income | 15.69 | 12.21 | 60.63 | 171.04 | -106.83 | 184.37 |
Interest Expense | -8.69 | -10.92 | -30.16 | -164.71 | -273.14 | -127.79 |
Interest & Investment Income | 1.13 | 1.13 | 1.49 | 2.39 | 4.96 | 8.25 |
Earnings From Equity Investments | - | - | - | - | - | 7.99 |
Currency Exchange Gain (Loss) | - | - | - | - | 10.03 | - |
Other Non Operating Income (Expenses) | -6.32 | 4.21 | -5.26 | 7.2 | 2.58 | -7.39 |
EBT Excluding Unusual Items | 1.82 | 6.64 | 26.7 | 15.93 | -362.39 | 65.43 |
Impairment of Goodwill | -44.78 | -44.78 | - | - | -1.44 | - |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 0.03 |
Gain (Loss) on Sale of Assets | 2 | 2 | 0.03 | 0.41 | 0.34 | 0.91 |
Asset Writedown | -16.81 | -16.81 | -180.49 | - | -121.29 | -41.58 |
Other Unusual Items | 1.14 | 1.14 | 1,083 | 24.71 | - | 35.16 |
Pretax Income | -56.64 | -51.82 | 929.64 | 41.04 | -484.78 | 59.94 |
Income Tax Expense | 24.16 | 17.35 | 26.67 | 39.56 | -10.83 | 47.26 |
Earnings From Continuing Operations | -80.8 | -69.17 | 902.98 | 1.48 | -473.95 | 12.68 |
Earnings From Discontinued Operations | - | - | 0.54 | -4.57 | -531.92 | - |
Net Income to Company | -80.8 | -69.17 | 903.51 | -3.09 | -1,006 | 12.68 |
Minority Interest in Earnings | -3.16 | -5.86 | 18.1 | -10.79 | 13.63 | -9.35 |
Net Income | -83.96 | -75.03 | 921.61 | -13.89 | -992.23 | 3.33 |
Net Income to Common | -83.96 | -75.03 | 921.61 | -13.89 | -992.23 | 3.33 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 2,332 | 2,332 | 2,332 | 2,332 | 2,332 | 2,347 |
Shares Outstanding (Diluted) | 2,332 | 2,332 | 2,332 | 2,332 | 2,332 | 2,347 |
Shares Change | - | - | - | - | -0.64% | -0.64% |
EPS (Basic) | -0.04 | -0.03 | 0.40 | -0.01 | -0.43 | 0.00 |
EPS (Diluted) | -0.04 | -0.03 | 0.40 | -0.01 | -0.43 | 0.00 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | 289.4 | -26.45 | 292.54 | -115.58 | 665.55 |
Free Cash Flow Per Share | - | 0.12 | -0.01 | 0.13 | -0.05 | 0.28 |
Gross Margin | 20.60% | 17.91% | 16.56% | 17.61% | 14.17% | 17.21% |
Operating Margin | 1.16% | 0.82% | 2.52% | 5.87% | -3.81% | 3.74% |
Profit Margin | -6.22% | -5.04% | 38.24% | -0.48% | -35.38% | 0.07% |
Free Cash Flow Margin | - | 19.42% | -1.10% | 10.04% | -4.12% | 13.50% |
EBITDA | 41.05 | 37.64 | 108.2 | 238.97 | 14.71 | 315.89 |
EBITDA Margin | 3.04% | 2.53% | 4.49% | 8.20% | 0.52% | 6.41% |
D&A For EBITDA | 25.36 | 25.43 | 47.57 | 67.93 | 121.54 | 131.52 |
EBIT | 15.69 | 12.21 | 60.63 | 171.04 | -106.83 | 184.37 |
EBIT Margin | 1.16% | 0.82% | 2.52% | 5.87% | -3.81% | 3.74% |
Effective Tax Rate | - | - | 2.87% | 96.40% | - | 78.85% |